Historical record - last NADAC publication: 10/3/2018
Product Information
PNV-DHA + DOCUSATE SOFTGEL is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $1.0766 per EA under NDC 42192032330. Its NADAC has been published 39 times since Jun 20, 2018.
PNV-DHA + DOCUSATE SOFTGEL
ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexentStrength
30; 28; 160; 400; 300; 27; 1.25; 25 [iU]/1; mg/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1
Manufacturer
Acella Pharmaceuticals, LLCNDC
42192032330
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
10/3/2018
Active Ingredients
.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM; CHOLECALCIFEROL; DOCONEXENT; FERROUS FUMARATE; FOLIC ACID; PYRIDOXINEApproval Type
Unapproved
On Market Since
10/1/2010
Pharmacological Classes
Price Statistics
The NADAC for PNV-DHA + DOCUSATE SOFTGEL has been published 39 times since Jun 20, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0766 per EA |
|---|---|
| All-time high | $1.0766 (Jun 12, 2019) |
| All-time low | $1.0766 (Jun 20, 2018) |
| Median price | $1.0766 |
| Average price | $1.0766 |
| Largest weekly change | 0.0% (Jun 27, 2018) |
| Weeks tracked | 39 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexent market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PNV-DHA + DOCUSATE SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for PNV-DHA + DOCUSATE SOFTGEL, manufactured by Acella Pharmaceuticals, LLC, is $1.0766 per EA (NDC 42192032330), effective Jun 12, 2019.
How has the price of PNV-DHA + DOCUSATE SOFTGEL changed over time?
Over the history we have for it, the NADAC for PNV-DHA + DOCUSATE SOFTGEL has held within roughly two percent of its current level. It has been tracked across 39 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for PNV-DHA + DOCUSATE SOFTGEL?
Since Jun 20, 2018, the NADAC for PNV-DHA + DOCUSATE SOFTGEL has ranged from a low of $1.0766 (Jun 20, 2018) to a high of $1.0766 (Jun 12, 2019), with a median of $1.0766 per EA.
Are there cheaper alternatives to PNV-DHA + DOCUSATE SOFTGEL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PNV-DHA + DOCUSATE SOFTGEL, so no direct lower-cost alternative is listed.
Who manufactures PNV-DHA + DOCUSATE SOFTGEL?
PNV-DHA + DOCUSATE SOFTGEL (NDC 42192032330) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification